26 Results

People

  1. Chan
    Chan
  2. Morris
    Morris
  3. Heguy
    Heguy
  4. Sander
    Sander
  5. Schultz
    Schultz
  6. Kuo
    Kuo
  7. Ladanyi
    Ladanyi
  8. Lee
    Lee
  9. Makarov
    Makarov
  10. Riaz
    Riaz

Groups

  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (26)
  2. GSK Faculty (26)
  3. Surgery (16)
  4. Department of Medicine (13)
  5. Human Oncology and Pathogenesis Program (12)
  6. Sloan Kettering Institute Postdocs (12)
  7. Solid Tumor Oncology Division (12)
  8. Epidemiology and Biostatistics (11)
  9. Tow Center for Developmental Oncology (TCDO) (9)
  10. Computational Oncology Service (8)
  1. "mutation"
  2. "Timothy Chan"
Formats
  1. Journal Article (24)
  2. Review (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (26)
  2. GSK Faculty (26)
  3. Surgery (16)
  4. Department of Medicine (13)
  5. Human Oncology and Pathogenesis Program (12)
  6. Sloan Kettering Institute Postdocs (12)

More Groups

People
  1. Timothy Chan (26)
  2. Luc Morris (9)
  3. Adriana Heguy (7)
  4. Chris Sander (7)
  5. Nikolaus Schultz (6)
  6. Fengshen Kuo (5)

More People

Years
  1. 2022 (3)
  2. 2021 (1)
  3. 2020 (2)
  4. 2019 (2)
  5. 2018 (1)
  6. 2017 (1)

More Years

Publications
  1. Nature Communications (4)
  2. Nature Genetics (3)
  3. Cell Cycle (2)
  4. Proceedings of the National Academy of Sciences of the United States of America (2)
  5. American Journal of Cancer Research (1)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. Nature Publishing Group (9)
  2. American Association for the Advancement of Science (2)
  3. National Academy of Sciences (2)
  4. Oxford University Press (2)
  5. Taylor & Francis Inc. (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (26)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity
    Journal Article

    Ma, X.; Riaz, N.; Samstein, R. M.; Lee, M.; Makarov, V.; Valero, C.; Chowell, D.; Kuo, F.; Hoen, D.; Fitzgerald, C. W. R.; more...
    Nature Genetics (2022)

    Fulltext@MSK | Save
  • Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine
    Journal Article

    Gigoux, M.; Holmström, M. O.; Zappasodi, R.; Park, J. J.; Pourpe, S.; Bozkus, C. C.; Mangarin, L. M. B.; Redmond, D.; Verma, S.; Schad, S.; more...
    Science Translational Medicine (2022)

    Fulltext@MSK | Save
  • Improved prediction of immune checkpoint blockade efficacy across multiple cancer types
    Journal Article

    Chowell, D.; Yoo, S. K.; Valero, C.; Pastore, A.; Krishna, C.; Lee, M.; Hoen, D.; Shi, H.; Kelly, D. W.; Patel, N.; more...
    Nature Biotechnology (2022)

    Fulltext@MSK | Save
  • Immune cytolytic activity is associated with reduced intra-tumoral genetic heterogeneity and with better clinical outcomes in triple negative breast cancer
    Journal Article

    Oshi, M.; Kawaguchi, T.; Yan, L.; Peng, X.; Qi, Q.; Tian, W.; Schulze, A.; McDonald, K. A.; Narayanan, S.; Young, J.; more...
    American Journal of Cancer Research (2021)

    Fulltext@MSK | Save
  • A pan-cancer analysis of PBAF complex mutations and their association with immunotherapy response
    Journal Article

    Hakimi, A. A.; Attalla, K.; DiNatale, R. G.; Ostrovnaya, I.; Flynn, J.; Blum, K. A.; Ged, Y.; Hoen, D.; Kendall, S. M.; Reznik, E.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice
    Journal Article

    Hoefflin, R.; Harlander, S.; Schäfer, S.; Metzger, P.; Kuo, F.; Schönenberger, D.; Adlesic, M.; Peighambari, A.; Seidel, P.; Chen, C. Y.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • The good, the bad, and the ugly: Hyperprogression in cancer patients following immune checkpoint therapy
    Review

    Sabio, E.; Chan, T. A.
    Genome Medicine (2019)

    Fulltext@MSK | Save
  • Development of tumor mutation burden as an immunotherapy biomarker: Utility for the oncology clinic
    Review

    Chan, T. A.; Yarchoan, M.; Jaffee, E.; Swanton, C.; Quezada, S. A.; Stenzinger, A.; Peters, S.
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling
    Journal Article

    Danussi, C.; Bose, P.; Parthasarathy, P. T.; Silberman, P. C.; Van Arnam, J. S.; Vitucci, M.; Tang, O. Y.; Heguy, A.; Wang, Y.; Chan, T. A.; more...
    Nature Communications (2018)

    Fulltext@MSK | Save
  • Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions
    Journal Article

    Dalin, M. G.; Katabi, N.; Persson, M.; Lee, K. W.; Makarov, V.; Desrichard, A.; Walsh, L. A.; West, L.; Nadeem, Z.; Ramaswami, D.; more...
    Nature Communications (2017)

    Fulltext@MSK | Save